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The management of recurrent &hernia in patients who have 
had previous saphettous vein bypass graft surgery poses a 
serious, difficult woblem. Recurrent ischemia occurs not 
ottly because of &t&ion of the saphenous vein @atIs hut 
also hacause of progression of coro ary artery disease in the 
native comaary arteries. The attrition rate is 15% to 20% 
duing the 1st year after opmdion; between I and 6 years 
afteropcratiw. it is 1% to Z%/year and between 6 to IO years 
atIer surgery the rate is 4%/year (l-8). By 5 years, about 
45% of the gratts are occluded (3.7). progression of native 
coronary artery disease occurs in appmximately 5% of the 
Tbziadwdbigbmska&&n(ea~pr&km. 
(1 An toll CmdkI 1993$?1:1539-49~ 
patients/year after operation @-II). Symptoms recur or 
progress in about 5% of patients/year, and it has been 
estimated that 10% to 15% of the patients will require a 
repeat operation within 10 years after the initial procedure 
(I l-15). However. curraatly imtxoved sumical techaiwes in 
combination with admiaio~rali~n of asp& aad riskfactor 
modification have improved the early graft attritkxt rate and 
may lessen long-term atbilion (16). DespiIe impmved surgi- 
cal results, it may be expected that fhe number of patients 
with recurrencc.ofischemiawill increasebecause thepoolof 
surgically treated patients continues to accumulate. 
Reoperation is technically more diicult to pm-form and is 
associated with a rather high m=ormlity rate (3% to 6.5%) aad 
a high p&operative myocardial infarction rate (3.4% to 
I I .S%). and the likelihood of comrdete relief of symptoms is 
less than with a first operaiion (il-16). These factors have 
stimulated the search for an alternative treatment. 
Gmentzig at al. (17) reported as early as 1979 that vein 
gaft argioplnsty was successful in five Of seven attempts. 
However, three cdfivegmtts demonstrated restenosis during 
follow-ap, and Gmentzig suggested that the “di5erent kind 
Fipre I. Bisiologic crow section of a 
‘)_month old saphenous vein bypass graft 
sboviog severe lun,cn narrowing due IO cow 
centric intilnal tbtcketig t-) consisting 
offibmcdlagmm~s tissue. Elaslic-van Giesca 
stain X25, w&wed by 29%. 
of disease” in the bypass graft may have cxp4ained the high RtbwSmlyofaQbewm-9nns.TbepathG- 
tecumnce rate in graft stenosis. Since then, many studies physiologic mecbanismr underlying gr&? failure can arbi- 
concerning angioplasty of lesions in sapbenous vein grafts barfly lx distinguiabed into lhose occurring early. within I 
have been reported. yearandtateafteropcmtAlneachperiodoaeaswmesa 
In this article we review the reported data and diw~ss the speciticpredm&Mtpgthcgenc(iemechsaism,alumughMK 
indications and the initial and late results of angidasty of must bear in mind that the different pgthcdogic pmcesvs 
saphenous vein bypass grafts. We also briefly discuss the may occur in a cmUinuaus fashion and overlap in titw 
mle of new techniques including stems, directional tad (18,19). 
extractional mherectomy and laser angioplasty. Oraft occIwdon early after opemtivn is usually associated 
with acute thrombmis (18.19). possibly attributable to haf- 
vesting and handI@ of the vein or to failure of surgical 
techaiqws at sites of anattomosis (20). 
Fibmintimal hyperplasia is the dominant feature I to 12 
months atIer opemt& (20-22). The ceils of fibmintimal 
hyprpksia resemble smooth muscle cells and sane cells 
may bwe a foamy cytopksmic appearance (21). Focally 
stewtic ksians pmdwed by this pacess appear panicukrly 
ameooMetodiktkfi. 
In tbe late pos~opcr&e period, fibtintimal hytwpksia 
sclerotic lesions bzcome more frequat &.. I &I 2) (19). 
The tibmintimal ksion maduattv diminishes its celhdmitv. 
and the smooth mwk& & qiaced by 6bmus t&s& 
and the matrix is incresxd. With lime, there appears to be 
an increase in the number of foam ceils within the iatima. 
The devetopmert of athmwckmsis in ths s0rtowmnm-y 
vein grafts is an impnrmm factor in late g7afl stenosis and 
occlusion (z-32). The atbenwckrc.tk plnceos pmceeds to a 
Rug developed compkx athzosakm6c ptaque WI. 31, and 
rupture of the plaque leads to a superimposed thrombotic 
occlusion (23,24). The plaques are often large, tiagile and 
ukerated and the graft may show aneurysmal dilation 
(25,26). 
There is still some controversy as to whether venousgraft 
atherosclerosis differs from coronary atherosclerosis. Some 
investigators (2X,29) suggest that vein graft lesioss contain 
more foam cells, end that they exhibit an intlammatory 
reaction with foreign body giant cells. This prowess uoder- 
mines the thickened intima, so that the fibrous cap is 
weakened (Fig. 4) (28). One study (29) demonstrated laik of 
a fibrous cap. This thinning and weakening of the fibrous cap 
may explain the greater propensity of venous plaque rupture 
and thrombosis. The propensity of thrombus fom&m in 
vein grafts is enlarged because the lack of side branches. the 
l&diameter of vessels end consequently low flow veloci- 
ties may contribute to platelet aggregation and thmmbus 
formation. These factors may explain the frequent occur- 
rence of thrombotic complications or embolization of mate. 
riol during balloon angioplasty. However, other investiga- 
tors (18,19.26,30-32) believe that atherosclerosis vein graft 
disease is not different from arterial atherosclerosis. 
Immediate rw~lts of nnglopIPrty for arphenous venom 
bypass grafts. Ford et al. (33) repotted a small series of 
seven patients of whom six underwent successful dilation. 
Since then, many centers have reported their initial results of 
angioplasty d saphenous veingrafts. Only the updated latest 
reports for eacS center are presented in Table I. 
The initial succe~r rate varies from 75% to 9446, with a 
combined overall success rate of 88%. The major complica- 
tion rate is low, with a procedure-related eath rate of <I%, 
a myocardial infarction rate of ==4% and a need for urgent 
coronary bypass graft wrgery of <2%. The remarkably low 
tendency to abrupt occlusion and the relatively hii success 
rate are p&ably due to the abseoce of side branches and 
tortuosity. The risk of embolization of friable, thrombotic 
material into the native circulation is <3%. Embolism oso- 
allyoccurrduringattemptedangioplasty in oldergrafts, with 
loog diseased segments containing friabk, thrombotic le- 
rions. The initial success rate depends on the site of dilation 
(TaMe 2). The werall combimd initial results of dilation of 
the proximal site is 87%. of the gmll body 94% and of the 
distal site !XI%. These rates appear to be similar except for a 
sliitly lower success rate for dilation a1 rhe proximal site. 
The high success rate and low complication rate reikct the 
careful selection of patients. DifFKult lesions with potential 
hii risk, such as loog disc lesions or ulcerated, tbnrm- 
bolic, friaMe lesions, were probably excluded from these 
series. 
Tabk 2. lnitid Succew Rale of Dilation of Saphemrus Vein 
Grafts et Diflerent Sites 
Tabk 3. Restenosis Afler Successful Angiopksty of Saphenous Venous Gmhs 
Reatenosis after suerraful dihtton of @woous vein 
grafts. The resteoosis rate (defined as >50% lumen diameter 
narrowing in the majority of the reported studies) after 
initially successful aogioplasty depeods highly on the site of 
dilation witbin the graft (Table 3). O&l or very proximal 
graft lesions tend to have a very bii resteoosis rate (56% on 
average). The restenosis rate of the body of the graR is 52% 
and the restmosis rate in the distal, aoastoowtic pat of the 
graft is 28%. The overall combined resteoosis rate is 42%. 
These data probably overestimate the tree incidence of 
resteoosis because oat all asymptomatic patients are restud- 
ied. The angiographic completeness of follow-up varied from 
56% to 100% in the reported studies (Table 3). 
In native comoary tier&, the restenosis pmcess takes 
place in the majority of the patients withio 6 months atter 
attgioplasty. It is oat koown whether the restenosis process 
in veooos bypass g&s is similar, but data repened by 
Douglas et al. (52) suggest that the interval is longer. lo 
follow-up studies of.599 patients with successfol angioplasty. 
restenosis was foood in 32% of dilated lesions within 6 
months of operation in 43% by 6 months to I year, in 61% by 
lto5yearsaodin64%after5years. 
I,ag4trm fdIow.ap afkr amgbpuy of wim 
bypan prpm. The long-term ootcome of patients selected 
for angioolast~ ofa saohenous vein bywss w-aft is influenced 
not only by the r&osis rate and Ate if progessioa of 
disease in the native arteries but also by the extent of the left 
ventricolar dysfooctioo. The fmqwocy of late death, myo- 
cardial iofarction and reconwe of angina is listed in Table 
4. The wide wage oftates Mlects the Menncer in patient 
selection and doratioo of follow-up. It appars that the 
clinical event rate is sieoiticaotlv bieher if the anft is older. 
The clinical event rate &s64% in&if& >36&mths old and 
33% in grafts <36 months dd (45). 
Plokker et al. (48) reported that, after a follow-up period 
of 5 yews. 74% of 454 patients were alive and ooly 26% of 
the patients wxe alive and event free (oo mycardkd iotkc- 
tion. no repeat bypass wgery or repeat aogiopkty) (Fig. 
5). The interval ktween aogioplast~ and bypass surgery was 
a sigoiticant prcdlctw for 5-year event-free survival. * 
event-free survival rates for patients who had bypass surgery 
I “ear before, between I sod 5 years and 5 years after bypass 
St&y were 45%. 25% and- IS% respktively. The -late 
mortality and late myocardii infarction rates are expected 
Pbkker (48) 1991 454 22 NR NR M 
Figwe 5. TIE cumulative probability cf survival of 4% patients 
f&wed up for 5 years. I = surviyBI: II = survival witbad acute 
myocardial infarction (A&IO; III = survival witbout acute mywar- 
dial infarction and without repeat comnwY artery bypass grafting 
WCABG), and IV = survival widtout any cardiac event W.th. 
acute myowdial infarction, comrvny artcry bypass graftiw or 
IW%I coronary balloon an&lasty (r&TCAJ. Reprcduced, with 
permission, from Flokker et al. (48). 
to be high because onen these patients present with eod- 
stage coronary artery disease. In these patients. eogbplasty 
should be considered a palliative treatment and one should 
not expect a beneticial effect on late mortality. 
BaaIilngk@qof~(wttbin1yrar)~d 
sspbenous veto bmga grafts. Graft occlusion occurring 
within 1 month after operation is almost always essocialed 
with grafI thrombosis (18-20,24,27). Technical fectors, such 
es stenosis et sureical aoastomotic sites or iotmooemtive 
vein trauma or p&r distal runoff due to severely diseesed 
native arteries. ulav a role and limit tlx ws9ibiliis of 
immediate and’s&incd btmeficial et&t of &gioplasty. 
Graft occlusion occurring between I month and I yew 
after ooemtion is chemcterized bv lesions coosistine of 
fibrointimat hyprplesia with ape&posed occlusive th&m- 
b&s (18~X24.27.28.30). These occlusioos ere aredomi- 
nmSly‘focal,‘no~ a&ia& with diffuse vein g&&ease, 
and usually the tbmmbotic component of the occlusion is not 
extensive. They appear to be amenable to successful perfo- 
ration and dilation. 
BIIloaD@@teStYdCtWktetettYadadedslpkllas 
vete arpgS grdte >1 yeer after opntiao. The uoderlyteg 
pathoanatomy plays an important mle io the expected suc- 
cess rate ofaagioplasty of a cbmoic totally occluded graft. 
Late occlusions (1 to 3 years postoperatively) are usueUy 
essociatcd with fccel atherosclerosis with occlusive Worn- 
bosis(M-21,24,27,2&M). These lesions may be amenable to 
succcssftd perfcaction md dilation witbout increased risk of 
thrombotic embolizetion. Older occlusive obstructions are 
often composed of Iqe, ulcerated p!%quc.s contaioiog fr able 
thrombotic mat&d. The chronic total occlusions are often 
e~.tendcd over a bug segment of the grcft and are often 
eesc&ted with difthse maft disease. Obviously, atforetioo 
and di!atiin oftbescch&c occlusions may be&cccssful 
or even lwmful because of di&dgmeot of material into the 
native corooery &&&ion with ensuiog myocardii infare- 
tion. 
The safety and results of m&plasty in occluded grafts 
a~.coatroversial. deFeytcret al. (53)repMedin 13patients 
with chrolrically totatly occMed old degeaemtcd grafts that 
attempts to mcaoaiii the gmft expose the patient to a bigb 
risk of cmbolizatioa and. even ifit is pos.sibk to rewen the 
graft, it frequently reoc&k~. In d&i study only i of 13 
Patients had e looHelm slexcss, Md tbe jmlcedlue was 
wmpliieted by P. myocud~al infamim in 5 pticms (TsMe 
5). Apparrntty, the presence oflarge emounts ofammbodc 
mate~eoditsdisb&mentaretbemeioceumdbw 
succe(~(~ and high a&lic&ms with balloon mgio+ty. 
TbaerestdtscootmsthwithueceatrewrtdIWmct 
rd.~),),whonpontdas3-~t(~~a2~) 
with P 1.5% it&spital death mtc, 3% q yocadial Stction 
late and no W@mt bypsss surgery. However, at 3-yur 
follow-up study, only 33% of lhe patients bad hat no repeat 
@oplesty or bypass surgery. The diSereoce in imm&te 
ewes in pctient rkctbn: RCS”ltd In shirt occluded stg- 
merds d gmfts with P reasxmebly oormal aaoiolraphic 
Talk 5. Gmmry Angioplasty of Chronic Totally Occluded Vein Gmfts 
s~earanee are probably belter than those in hmg occluded 
segments of degawated vein gmtk. 
Pre’lreatment of chronic total occlusion with umkinase 
fdowedby angioplasty. Dissolving thrombus in chnxtically 
occlwkd grafts with a short infusion of umkinax dramati- 
cally improved the short- and long-term results of an@ 
plasty (Table 4). Sievert et al. (55) showed that, after 
Tabk 6. Sent Implantation i Venous Bypa Grafts 
pretreatment with urokimse. six of seven patimts had 
successful recanaliwion, and fwr patkntr had loil~term 
s”ccess. Hatmann et al. (56) also show& 6wJ results with 
loa&-iig-tc;nr urokinve infusion (range 7.5 h to 77 b [mgn 311) 
followed by angiop(asty. R-i was achieved more 
easily in patients with a short estimated duration of occlu- 
Con. The price for this treatment was the occurrcna of a 
significant hematoma in 22% of the wients and a low stav 
in a comMrY care unit. unf&tely. the rewet;sti 
restenosis rate was ratba hii. and w-ass war sustained in 
48%(22 of46) ofthe prrtknts during I to 24(meatt II) months 
of follow-up. Levine et al. (57) demonstrated that pakttcy 
was achieved in 8 of 10 patients. However, two patients died 
and two had emlwlk myocardkl infection, awl no ~&III 
was free of reocclusion, mywudial i&&on or death 
during a fdlow-up period of an average of 13 * 6 months. 
hkn~tkaaf*Mrrhr~oakomt. 
Variables predicfive ofwfavoralde initial rmdts. Factors 
that predict a twos initial result inch&d 1) diiners of 
saphenous veil prai: disease (40); 2) au&ted an&&sty 
uf steams in g&s >4 to 6 years dd (45.46); 3i &TO& 
tolall~ acluded tis (13); and 4) the mesel~e ofintnwein 
@t ihrombus (i9). The prr~ncc of &ae or more of these 
variables is aswciated with a b&h frequency of major 
complications (death, myaxdial infarction and wed for 
urgent bypass surgery). oRen due to embalizaticm of friable 
material into the comnary circulation or the occurrence of 
abrupt occlusion with thrombosis t&mat&t. 
Varia6les pwiictive of rate mtelws~. These in&k 
I) lesions in old (z-36 months) grafts (restnosis rate 83% vs. 
42%) (45); 2) multipk k&as. diiuw gaft disease and total 
occlusion (NM% vs. 3896) (49): 3) small diameter W2.2 mm) 
of tbz grafted comasty artery (78% vs. 27%) (58); 4) kr@h 
of stenosis >I0 mm) (62% Vs. 12%) (581: and 51 diMon of 
lesion at the pmtisite and body of the grafi @bk 3). 
Liiliowd~ backq. In many eemnthe avail- 
ability of immediate wgkal backup is cmnidercd a prcrcq- 
uisite for performing angiqksty. Although emergency op 
eration for acute ixhemia may wt totatty eliminate the 
development of myoadial infarction, there is evidence that 
Flgc 7. Acluarial event-free survival of 145 palients followed up 
for up lo 20 months alter stat implantation in a bypass &l. The 
caries (from uwr to lowerl represent freedom tiom dsatb MYTH) 
alone: death plus myocardial infarction (MI); death, myocardial 
infarction plus coronary bypass surgery (BYP); and death, myocar- 
dial infarction, coronary bypass urgery plus angioplasly or athexe 
tmny @‘I’). Reproduced, with permission, fmm Strauss et al. (67). 
pmmpt revascttlarization does limit the damage (59). The 
time between the onset of &hernia and revascolarization 
determines the outcome (60). The ischemic period during 
reoperation is considerably prolonged because immediate 
access to the heart is hampered by the fibrosis of the 
previous operation, which may require considerable time to 
dissect free the heart. This inevitable delay limits the poten- 
tial of revascohuization to reduce myocardial damage. If 
possible, bailout techniques, such as use of autoperfusion 
catheters, should aMys be used in these situations. Stent 
implantation for threatened closure has produced satisfac- 
tory results (61). 
This expected time delay should bp considered when 
counseling a patient. It would be prudent to refer a patient 
for reoperation if, for instr ICC, abrupt closure of a lesion 
would lead to acute heart failure due to the large area of 
myocardium at risk. 
New interventhmal technlqoes for treatment of sapbenaua 
vein bypass graL. Srenr imploaration. The intmcoronary 
stent was the first of the new interventional techniques to be 
applied in bypass ~mft an&4asty. Shortly after the intro- 
duction into the native coronary artery system, stents were 
also imolaoted in brass aratls (Fin. 6) (62-64). The imme- 
diate &ogmphic.&d &~pk&&n ‘s&e& rate is ex- 
tremely high (295%. Table@ (61.62.64-66). However, early 
experience was associated with an unacceptable high 
incidence of subacute thrombosis and serious bleeding corn- 
plications. Increased operator experience and meticulous 
amicoagolation resulted in a substantial decrease in compli- 
cations (64-66). UnfortunateIy, the incideoce of restewsis 
do-as not seem to have been reduced (Table 6). One detailed 
study ML restenoais after Wall stent implantation in venous 
bypass grafts reports ao incidence of resteoosis of 3% 
according to the 5G% diametu stenosis criterion (67). me 
resteo&s rate was 35% after implantation of a flexible coil 
(61) and <ZS% after implantation of a Palmaz-khatz stem 
(68). Restenosis occurred more freaoentlv after Wallstent 
&hntatim in bypass g&s than in &eoteh native comwy 
arteries (69). The rates were aim&r in graft8 aad native 
arteries after Palmaz-Schatz stent implantation (68). 
Whether the better results obtabwd with the Palmae-Schata 
were due to the more favorable features of this steot or to 
improved &mwdural phmmacologic management or dif. 
ferent patient selection is unknown. 
The lottgt~ clinical follow-up results of Wallstent 
implantation in bypass grafts collected from 145 Patients of 
six European centers is shown in Figure 7 (67). The actuarial 
event-free aorvival (freedom from death, myowdii infarr- 
tion, bypars surgery or aogioplas(y) for bypass gmft patleots 
was 37% at 20 months with an overall mmiality rate of%. 
About 30% of the adverse events were uorelated to the 
steoted lesion and were doe to wonening of dilferent ksioor 
or to development of new ksions (64,67). 
Afkrecfom~: direcfional and extractional. The USC of 
dhzctlonal atherectomy in aapheacus venooa bypass grafts 
was feasible and sucwsfol in >9C% of oatlents (Table 7) 
@5,70,71). The complication rate wps ac;ep(able; but o& 
can imagine that the use of such a bulky device in case of 
friable, thrombutic lesions easily embolizes material. F&m- 
inary data suggest hat the restenosis rate is also high. 
Extraetionai atherectomy of vein graft lesions was suc- 
ceatitl in 69% of patients (Table 7) (72). The complication 
rate was low and the restenosis rate WI 53%. It is conceiv- 
able that the use of this device in vein grafts containing much 
material is safe and is associated with a higher SUECCSS rate 
and decreased risk of embolization due to the suction, 
extraction and removal of material with this device, although 
embolization occurred in 3.5% of oatients. 
Excimer laser angiophty. In-an initiaI experience i - 
cludina 22.5 oatients (Table 7L it was shown that excimer 
hS.21 &O&&y Ct& be p&&d safely end &eCtiVely 
(73). A .wcce~s rate of 97% was achieved in lesions in older 
saphenous vein grafts; however, the preliminary repmed 
nstenosis rate of 61% was rather hii. 
Cmdmlaas. Currently sufficient data are lacking to es- 
tablish the merits of reoperation and balloon angiaplaay to 
treat obsIrttctions in venous bypass g&s. The published 
compaml of dbTcrences in”pa~iett~selection, and 
tirm conclusionP about the supcriotity of one treatment 
above the other should not be drawn. A review of the 
published data indicates that in selected patients ballooo 
an&&sty may be the ptefetred strategy and, in case of 
itwembility, it is the only strategy. 
A&o&w of twocclusive obstructions in vetate by- 
pass @Is is safe and the success rate is high. The high 
restenosis rate adversely z&cts the lottgwm molts. The 
kttmediate arid long-term results of aogioplasty for chronic 
total aclusion in old grafts arr poor. 
Patiett~s cottsidend for saphenoos vein graft angioplasty 
may be claG6ed into three groups according to expected 
early and late outcome: I) those with zm initial high success, 
low procedural risk and low rateoasis rate; 2) those with an 
initial high success but hi pmeedmal risk and moderate to 
high restenosis rate; and 3) thase with a low success. hi& 
risk and high rewwsis rate (Table 8). 
New techniques have shown to be pomising and stent 
placement, in particular, may be useful to “tags ftiable 
material. However, definite conclusions ;amcemir&he mer- 
its of new techniques must await tiaalization of ongoing 
randomized trials. Balloon aeioplzty is a palliative pzoce. 
due, not a long-temt solution in patients ptwicusly oper- 
ated on, who oflen present with late-stage cormtaw artery 
disease. The hiti restettosis rate is a serious limitation of 
balloon angiopl&y. 
JACC “0,. a, NO. 7 
June ,991:15,9-49 

